Mitral valve regurgitation has been described as a very common cardiac valvular abnormality which is under recognized and under treated even in industrialized countries. This condition can be either because of “sick valve apparatus” where valve is defective and heart muscle suffers due to this OR “sick heart” where heart is enlarged and does not let the valve close completely when needed which causes valve to leak.
In US alone there is annual incidence of nearly 250K and only 30K gets addressed (includes adequately treated and recognized but not treated adequately). The reasons for this treatment lag are very complex which includes the very complex nature of the mitral valve compared other valves in the heart. If it is not timely recognized and adequately treated, it can lead to congestive heart failure, irreversible loss of heart pump function and higher morbidity and mortality.
Medical community at Shelby Baptist Medical Center which includes the cardiologists at Heart South PC are now capable of offering wide range of treatment options for these patients under the “Comprehensive Valve Therapy” program. This includes regular grand old method of sternotomy, minimal incision valve repair and most recently percutaneous treatment options for prohibitively high risk surgical patients such as Mitraclip. If the patients don’t fit any of these, the team is working on getting the research projects to the facility with cutting edge technology where patients will have opportunity to be enrolled into those studies.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: